{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [
    "Massachusetts General Hospital, Boston, MA, USA",
    "1Massachusetts General Hospital, Boston, MA, USA",
    "Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA",
    "Mass General Brigham Cancer Institute, Boston, Massachusetts, USA",
    "Medical University of South Carolina, Charleston, SC, USA"
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 9,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Aleigha Lawless"
    },
    {
      "affs": [
        1
      ],
      "name": "Tatyana Sharova"
    },
    {
      "affs": [
        1
      ],
      "name": "Moshe Sade-Feldman"
    },
    {
      "affs": [
        1
      ],
      "name": "Hongyan Xie"
    },
    {
      "affs": [
        2
      ],
      "name": "Jacy Fang"
    },
    {
      "affs": [
        3
      ],
      "name": "Sonia Cohen"
    },
    {
      "affs": [
        0
      ],
      "name": "Genevieve M Boland"
    },
    {
      "affs": [
        2
      ],
      "name": "Sarah E San Vicente"
    },
    {
      "affs": [
        4
      ],
      "name": "Russell W Jenkins"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/ab0yzd5vxfbm9.bib",
  "cited_by": 0,
  "doi": "10.1136/jitc-2026-sitc2026.0357",
  "fulltext_url": null,
  "id": "ab0yzd5vxfbm9",
  "issns": [
    "2051-1426"
  ],
  "landing_url": "https://doi.org/10.1136/jitc-2026-sitc2026.0357",
  "language": "en",
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "journal",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "lcc",
      "RC254-282"
    ],
    [
      "openalex",
      "2730|Cancer Immunotherapy and Biomarkers"
    ]
  ],
  "openalex": "W7225197742",
  "pdf_url": "https://jitc.bmj.com/content/14/Suppl_2/A400.full.pdf",
  "pmcid": null,
  "pmid": null,
  "published": "2026-11-06",
  "publisher": "BMJ Publishing Group",
  "ris": "https://research.draconitic.com/paper/ab0yzd5vxfbm9.ris",
  "sources": [
    {
      "first_seen": "2026-11-06T14:21:10Z",
      "native_id": "5dffcf721b004c2c8aa17e2cf6509f40",
      "source": "doaj",
      "url": "https://doi.org/10.1136/jitc-2026-sitc2026.0357"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2730|Cancer Immunotherapy and Biomarkers",
      "subfield": "oncology"
    }
  ],
  "title": "357 Mechanisms of LGALS3BP-driven resistance to TIL therapy",
  "title_text": "357 Mechanisms of LGALS3BP-driven resistance to TIL therapy",
  "type": "peer-reviewed",
  "updated_at": "2026-11-06T14:21:10Z",
  "url": "https://research.draconitic.com/paper/ab0yzd5vxfbm9",
  "venue": "Journal for ImmunoTherapy of Cancer",
  "versions": []
}